Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To compare the effectiveness and safety of Dysport® with the domestic Botulinum Toxin Type A
(manufactured by Lanzhou Biologic Product Institute, P.R. China) for the treatment of
hemifacial spasm.
Phase:
Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA